Characterization of PsTX-60B, a new membrane-attack complex/perforin (MACPF) family toxin, from the venomous sea anemone Phyllodiscus semoni.

Characterization of PsTX-60B, a new membrane-attack complex/perforin (MACPF) family toxin, from the venomous sea anemone Phyllodiscus semoni. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Characterization of PsTX-60B, a new membrane-attack complex/perforin (MACPF) family toxin, from the venomous sea anemone Phyllodiscus semoni. Abstract Text:

Hiroshi Satoh,Naomasa Oshiro,Setsuko Iwanaga,Michio Namikoshi,Hiroshi Nagai,

The sea anemone Phyllodiscus semoni has been known as one of the most venomous sea anemones. Previously, we reported the isolation of the major lethal protein toxins, PsTX-60A and PsTX-60B, from P. semoni and the primary structure of PsTX-60A. In this paper, we report the complete sequence of cDNA (1600 base pairs) encoding PsTX-60B and the deduced primary structure (488 amino acids) of PsTX-60B. The amino acid sequence of PsTX-60B showed the homology with those of PsTX-60A and Actineria villosa toxin, AvTX-60A. The results showed that PsTX-60B is a new member of the membrane-attack complex/perforin (MACPF) family toxin.

Characterization of PsTX-60B, a new membrane-attack complex/perforin (MACPF) family toxin, from the venomous sea anemone Phyllodiscus semoni. Publishing Authors By Initials

H Satoh,N Oshiro,S Iwanaga,M Namikoshi,H Nagai,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Characterization of PsTX-60B, a new membrane-attack complex/perforin (MACPF) family toxin, from the venomous sea anemone Phyllodiscus semoni. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Toxicon : official journal of the International So

VOLUME: 49

Page Numbers: 1208-10

Journal Abbreviation: Toxicon

ISSN: 0041-0101

DAY: 25

MONTH: 01

YEAR: 2007

Characterization of PsTX-60B, a new membrane-attack complex/perforin (MACPF) family toxin, from the venomous sea anemone Phyllodiscus semoni. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 1307333

Characterization of PsTX-60B, a new membrane-attack complex/perforin (MACPF) family toxin, from the venomous sea anemone Phyllodiscus semoni. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Characterization of PsTX-60B, a new membrane-attack complex/perforin (MACPF) family toxin, from the venomous sea anemone Phyllodiscus semoni. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Characterization of PsTX-60B, a new membrane-attack complex/perforin (MACPF) family toxin, from the venomous sea anemone Phyllodiscus semoni.

AFFILIATION: Tokyo University of Marine Science and Technology, 4-5-7 Konan, Minato-ku, Tokyo 108-8477, Japan.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Toxicon

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Characterization of PsTX-60B, a new membrane-attack complex/perforin MACPF family toxin, from the venomous sea anemone Phyllodiscus semoni Related Publications

• A pigmented calcifying cystic odontogenic tumor associated with compound odontoma: a case report and review of literature.
• Amiodarone and N-desethylamiodarone enhance endothelial nitric oxide production in human endothelial cells.
• Annual abdominal ultrasonographic examination after curative NSCLC resection.
• Capacity analysis for a two-level decoupled Hamming network for associative memory under a noisy environment.
• Characterization of PsTX-60B, a new membrane-attack complex/perforin (MACPF) family toxin, from the venomous sea anemone Phyllodiscus semoni.
• Cloning and characterization of rat casein kinase 1epsilon.
• Development of bovine in vitro-matured follicular oocytes activated with ethanol.
• Effects of central injection of l-carnosine on sympathetic nerve activity innervating brown adipose tissue and body temperature in rats.
• Full-term development of in vitro-matured, vitrified and fertilized bovine oocytes.
• High-throughput solid-phase extraction of metal ions using an iminodiacetate chelating porous disk prepared by graft polymerization.
• Identification of deamidation and isomerization sites on pharmaceutical recombinant antibody using H(2)(18)O.
• Immobilized rhBMP-2/succinylated type I atelocollagen gene expression of intracellular signaling molecules on ST2 cells.
• Immunolocalization of cell signaling molecules in the granular cell ameloblastoma.
• Inhibitory effect of palatinose on glucose absorption in everted rat gut.
• Isolation and characterization of a novel protein toxin from fire coral.
• Lactobacillus Acidophilus strain L-92 regulates the production of Th1 cytokine as well as Th2 cytokines.
• Mastoid obliteration by BMP-2/collagen composites: an experimental study using tissue engineering.
• Minimum leakage rate (0.5%) of stapled esophagojejunostomy with sacrifice of a small part of the jejunum after total gastrectomy in 390 consecutive patients.
• Morbidity prevalence rate of kawasaki disease assessed by single cross-sectional history-taking.
• Natural course of lower urinary tract symptoms following discontinuation of alpha-1-adrenergic blockers in patients with benign prostatic hyperplasia.
• Nutritional status and risk of amyotrophic lateral sclerosis in Japan.
• Preparation and characterization of platinum-ruthenium bimetallic nanoparticles using reverse microemulsions for fuel cell catalyst.
• Production of platelet-activating factor during focal cerebral ischemia and reperfusion in the rat.
• Salvage esophagectomy following definitive chemoradiotherapy.
• Solid tumor resection by use of a highly sensitive micromagnetic needle detection system.
• Subjective effect of magnetic resonance-guided focused ultrasound surgery for uterine fibroids.
• Thrombomodulin is a clock-controlled gene in vascular endothelial cells.
• [A case of loxoprofen sodium-induced eosinophilic pneumonia that occurred ipsilaterally after VATS lobectomy for lung cancer]
• [Cardiac gene therapy]
• [Trends in molecular targeting therapeutics for chronic myeloid leukemia]